Apollomics (APLM) SEC Filings: History & Chart

Apollomics, Inc.(APLM)

Biotechnology · Foster City, CA

$23.40+0.13 (+0.58%)

Delayed quote: Oct 6, 2026, 11:29 AM EDT

About Apollomics, Inc.

Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.

Foster City, CA

14 employees

www.apollomicsinc.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Hung-Wen Chen

View full financials

Form	Filing Date	Accepted	Document
4/A	Sep 24, 2026	Sep 24, 2026	View filing
4/A	Sep 24, 2026	Sep 24, 2026	View filing
4/A	Sep 24, 2026	Sep 24, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
4	Sep 17, 2026	Sep 17, 2026	View filing
424B3	Sep 8, 2026	Sep 8, 2026	View filing
4	Aug 24, 2026	Aug 24, 2026	View filing
D	Aug 19, 2026	Aug 18, 2026	View filing
4	Aug 17, 2026	Aug 17, 2026	View filing
4	Aug 17, 2026	Aug 17, 2026	View filing
4	Aug 17, 2026	Aug 17, 2026	View filing
SC 13D/A	Aug 17, 2026	Aug 17, 2026	View filing
SC 13D/A	Aug 14, 2026	Aug 14, 2026	View filing
6-K	Aug 12, 2026	Aug 11, 2026	View filing
3	Jul 24, 2026	Jul 24, 2026	View filing
6-K	Jul 21, 2026	Jul 21, 2026	View filing
6-K	Jul 14, 2026	Jul 14, 2026	View filing
6-K	Jun 24, 2026	Jun 24, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing

SEC Filings

Recent Filings